The Myeloproliferative Disorders (MPD) Research Consortium focuses on the Philadelphia (Ph) chromosome negative MPD including Polycythemia Vera (PV), and Idiopathic Myelofibrosis (IM) and has the following goals: 1) Establish a multi-institutional international research group entitled the """"""""MPD Research Consortium"""""""" which will coordinate and facilitate basic and clinical research dealing with the cellular and genetic basis of the Ph negative MPD. 2) Establish a multi-institutional MPD Clinical Consortium to enable uniform, high volume sample collection, storage and distribution. 3) Perform rationally designed clinical trials in patients with Ph negative MPD at multiple institutions. 4) Maintain an interactive website for MPD Consortium investigators, a sophisticated international tissue bank and an on-line database that will allow for integration of basic and clinical research. This unique interactive relationship between talented basic researchers and clinical scientists will permit the MPD Research Consortium to develop novel clinical treatment programs for Ph negative MPD and to identify specific biomarkers that will be useful as indicators of therapeutic response and/or risk reduction. This program has six major projects: Project 1: Genetic Basis of Polycythemia Vera, Principal Investigator: Josef T. Prchal; Project 2: Mechanisms and Effects of NF-E2 and PRV-1 Overexpression in PV: Role of Jak2V617F, Principal Investigator: Heike L Pahl; Project 3: Animal Models of Polycythemia Vera, Principal Investigator: Jerry Spivak; Project 4: Mouse Models of Myelofibrosis, Principal Investigator: Anna Rita Migliaccio; Project 5: Abnormal Stem Cell Trafficking in Myelofibrosis, Principal Investigator: Ronald Hoffman; Project 6: MPD Clinical Consortium which will pursue clinical trials in PV and IM, Principal Investigator: Lewis Silverman and Co-Principal Investigator: Tiziano Barbui. The six projects will be supported by one core: Tissue Bank, Principal Investigator: Rona Weinberg. These unique interactions between clinical and laboratory investigators which are interwoven within the MPD Research Consortium will ultimately result in improved understanding of the pathobiology of the Ph negative MPD as well improved strategies that will assist in the diagnosis and treatment of these disorders. ? ? ? ?

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Merritt, William D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Gilles, Laure; Arslan, Ahmet Dirim; Marinaccio, Christian et al. (2017) Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis. J Clin Invest 127:1316-1320
Varricchio, Lilian; Falchi, Mario; Dall'Ora, Massimiliano et al. (2017) Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function. Front Cell Dev Biol 5:96
Zingariello, M; Sancillo, L; Martelli, F et al. (2017) The thrombopoietin/MPL axis is activated in the Gata1(low) mouse model of myelofibrosis and is associated with a defective RPS14 signature. Blood Cancer J 7:e572
Falchi, Mario; Varricchio, Lilian; Martelli, Fabrizio et al. (2017) The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera. Exp Hematol 50:53-76
Lanikova, Lucie; Reading, N Scott; Hu, Hao et al. (2017) Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer. Oncotarget 8:11739-11747
Sergueeva, Adelina; Miasnikova, Galina; Shah, Binal N et al. (2017) Prospective study of thrombosis and thrombospondin-1 expression in Chuvash polycythemia. Haematologica 102:e166-e169
Wang, Linghua; Wheeler, David A; Prchal, Josef T (2016) Acquired uniparental disomy of chromosome 9p in hematologic malignancies. Exp Hematol 44:644-52
Klionsky, Daniel J (see original citation for additional authors) (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1-222
Migliaccio, Anna Rita (2016) To condition or not to condition-That is the question: The evolution of nonmyeloablative conditions for transplantation. Exp Hematol 44:706-12
Spangrude, Gerald J; Lewandowski, Daniel; Martelli, Fabrizio et al. (2016) P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis. Stem Cells 34:67-82

Showing the most recent 10 out of 181 publications